PA
EXAS

Parallel Advisors’s Exact Sciences EXAS Stock Holding History

Parallel Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-919
Closed -$93.4K – 3874
2025
Q4 		$93.4K Sell
919
-260
-22% -$20.9K ﹤0.01% 1503
2025
Q3 		$64.6K Buy
1,179
+380
+48% +$19K ﹤0.01% 1660
2025
Q2 		$42.5K Buy
799
+436
+120% +$22.1K ﹤0.01% 1817
2025
Q1 		$15.7K Sell
363
-176
-33% -$8.91K ﹤0.01% 2254
2024
Q4 		$30.3K Sell
539
-234
-30% -$14.6K ﹤0.01% 1939
2024
Q3 		$52.7K Buy
773
+325
+73% +$18.3K ﹤0.01% 1602
2024
Q2 		$18.9K Sell
448
-80
-15% -$4.4K ﹤0.01% 2027
2024
Q1 		$36.5K Sell
528
-106
-17% -$6.71K ﹤0.01% 1648
2023
Q4 		$46.9K Buy
634
+12
+2% +$787 ﹤0.01% 1459
2023
Q3 		$42.4K Sell
622
-8
-1% -$679 ﹤0.01% 1468
2023
Q2 		$59.2K Buy
630
+9
+1% +$702 ﹤0.01% 1322
2023
Q1 		$42.1K Buy
621
+29
+5% +$1.86K ﹤0.01% 1461
2022
Q4 		$29.3K Buy
592
+88
+17% +$3.6K ﹤0.01% 1537
2022
Q3 		$16K Buy
504
+48
+11% +$1.98K ﹤0.01% 1776
2022
Q2 		$18K Buy
456
+57
+14% +$3.05K ﹤0.01% 1710
2022
Q1 		$28K Sell
399
-424
-52% -$31K ﹤0.01% 1559
2021
Q4 		$64K Sell
823
-313
-28% -$27.6K ﹤0.01% 1200
2021
Q3 		$108K Buy
1,136
+479
+73% +$50.6K ﹤0.01% 951
2021
Q2 		$82K Buy
657
+71
+12% +$8.47K ﹤0.01% 1015
2021
Q1 		$77K Buy
586
+24
+4% +$3.29K ﹤0.01% 991
2020
Q4 		$74K Buy
562
+28
+5% +$3.39K ﹤0.01% 939
2020
Q3 		$54K Sell
534
-367
-41% -$31.7K ﹤0.01% 1032
2020
Q2 		$78K Buy
901
+107
+13% +$8.55K 0.01% 862
2020
Q1 		$46K Sell
794
-149
-16% -$12.1K ﹤0.01% 977
2019
Q4 		$87K Buy
943
+145
+18% +$12.7K 0.01% 833
2019
Q3 		$72K Buy
798
+27
+4% +$3.08K 0.01% 839
2019
Q2 		$91K Buy
771
+300
+64% +$30.2K 0.01% 688
2019
Q1 		$41K Buy
471
+312
+196% +$26.6K ﹤0.01% 921
2018
Q4 		$10K Buy
159
+133
+512% +$9.13K ﹤0.01% 1328
2018
Q3 		$2K Hold
26
– – ﹤0.01% 1995
2018
Q2 		$1K Buy
+26
New +$1.4K ﹤0.01% 1967
2017
Q3 		– Sell
-5
Closed – – 2127
2017
Q2 		$0 Buy
+5
New +$154 ﹤0.01% 2127

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Parallel Advisors's EXAS Position: Q1 2026 in Review

Parallel Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 919 shares — an estimated $93.4K sold.

Parallel Advisors first reported a position in EXAS in Q2 2017 and held it in 32 quarters. The position peaked at $108K in Q3 2021. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Parallel Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Parallel Advisors sold 919 Exact Sciences shares in Q1 2026, an estimated $93.4K.
  • Parallel Advisors first reported a position in Exact Sciences in Q2 2017 and held it in 32 quarters.
  • Parallel Advisors's Exact Sciences position peaked at $108K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.